Santarus (Nasdaq: SNTS) reported earnings on Nov. 7. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Sep. 30 (Q3), Santarus beat expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue grew significantly and GAAP earnings per share expanded significantly.

Gross margins dropped, operating margins grew, net margins increased.

Revenue details
Santarus recorded revenue of $54.7 million. The four analysts polled by S&P Capital IQ foresaw revenue of $53.0 million on the same basis. GAAP reported sales were much higher than the prior-year quarter's $26.8 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.13. The four earnings estimates compiled by S&P Capital IQ predicted $0.10 per share. GAAP EPS of $0.13 for Q3 were much higher than the prior-year quarter's $0.01 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 66.8%, 970 basis points worse than the prior-year quarter. Operating margin was 16.9%, 1,440 basis points better than the prior-year quarter. Net margin was 16.4%, 1,430 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $59.5 million. On the bottom line, the average EPS estimate is $0.02.

Next year's average estimate for revenue is $205.7 million. The average EPS estimate is $0.18.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 123 members out of 135 rating the stock outperform, and 12 members rating it underperform. Among 26 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 22 give Santarus a green thumbs-up, and four give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Santarus is buy, with an average price target of $10.44.